StonvexLoading…
StonvexCore line items from CRCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $109.82M | $15.17M | $19.86M |
Operating Income | $-96.44M | $167.16M | $269.53M |
Net Income | $-69.51M | $155.67M | $267.56M |
EPS (Diluted) | $-0.44 | $0.30 | $0.78 |
Total Assets | $78.71B | $45.83B | Not available |
Total Liabilities | $75.38B | $44.12B | Not available |
Cash & Equivalents | $1.53B | $750.98M | $368.62M |
Free Cash Flow OCF − CapEx | $529.70M | $326.45M | $138.91M |
Shares Outstanding | 158.70M | 73.04M | 67.55M |